Amoneta announces the CE-marking under the EU-IVDR of its APO-Easy® Genotyping Kit.
From June 24 to 27, 2024, Amoneta's parent company Firalis hosted at its premises in Huningue a Summer School for the CombiDiag Do...
Amoneta Diagnostics' innovative diagnostic tools are now available on the MedicalExpo platform
Amoneta Diagnostics announces its participation in the forthcoming AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases in Lisbon.
Huningue, France, December 12, 2023Together, Amoneta Diagnostics and the AD Data Initiative announce a collaboration to make data...
Amoneta Diagnostics announces that it has become a member of the Pépinière d'entreprises innovantes pH8, the region's premier business incubator focusing on healthcare and new technologies.